132 related articles for article (PubMed ID: 29075491)
1. Aldehyde dehydrogenase 1 expression has prognostic significance in patients with glioma.
Wang J; Yang CL; Zou LL
Mol Clin Oncol; 2017 Nov; 7(5):885-890. PubMed ID: 29075491
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
[TBL] [Abstract][Full Text] [Related]
3. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis.
Wang J; Xiang C; Cai Y; Mei Z; Lu Q; Liu B; Zou L
Arq Neuropsiquiatr; 2022 Dec; 80(12):1254-1261. PubMed ID: 36580964
[TBL] [Abstract][Full Text] [Related]
5. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.
Kong X; Wang Y; Liu S; Xing B; Yang Y; Li Y; Ren Z; Su C; Ma W; Wang R
Mol Neurobiol; 2016 Jul; 53(5):3503-3512. PubMed ID: 26884265
[TBL] [Abstract][Full Text] [Related]
6. The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis.
Lv S; Dai C; Liu Y; Shi R; Tang Z; Han M; Bian R; Sun B; Wang R
Mol Neurobiol; 2015; 51(3):1462-7. PubMed ID: 25063470
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of microRNA-155 expression in gliomas: A meta-analysis.
Zhou Y; Wang X; Liu Z; Huang X; Li X; Cheng K; Jiang X
Clin Neurol Neurosurg; 2019 Jan; 176():103-109. PubMed ID: 30554090
[TBL] [Abstract][Full Text] [Related]
8. The clinical and prognostic impact of aldehyde dehydrogenase 1 in non-small cell lung cancer: a meta-analysis.
Xue J; Zhao Y; Zou Q; Liang F; Lin F
Transl Cancer Res; 2020 Mar; 9(3):1914-1925. PubMed ID: 35117538
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Lv S; Sun B; Zhong X; Dai C; Wang W; Ma X; Song H; Shi R; Wang R
Mol Neurobiol; 2015 Aug; 52(1):555-61. PubMed ID: 25213993
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.
Li C; Sun J; Xiang Q; Liang Y; Zhao N; Zhang Z; Liu Q; Cui Y
J Neurooncol; 2016 Oct; 130(1):11-17. PubMed ID: 27531352
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Liu Y; Li D; Shi R; Tang Z; Fan J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):38-44. PubMed ID: 25108671
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Zhou X; Liu Y; Li D; Shi R; Kang H; Zhang J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):270-6. PubMed ID: 25148935
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Implications of Human Telomerase Reverse Transcriptase Expression in Grade and Prognosis of Gliomas: a Systematic Review and Meta-analysis.
Li J; Li H; Liu J; Feng B; Feng M; Lv B; Cheng S; Yang X
Mol Neurobiol; 2016 Jul; 53(5):2887-2893. PubMed ID: 25895660
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis.
Liu S; Liu C; Min X; Ji Y; Wang N; Liu D; Cai J; Li K
PLoS One; 2013; 8(11):e81050. PubMed ID: 24282568
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis.
Zhao W; Zang C; Zhang T; Li J; Liu R; Feng F; Lv Q; Zheng L; Tian J; Sun C
Onco Targets Ther; 2018; 11():1821-1831. PubMed ID: 29662319
[TBL] [Abstract][Full Text] [Related]
20. ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Wei D; Peng JJ; Gao H; Zhang T; Tan Y; Hu YH
Heart Lung Circ; 2015 Aug; 24(8):780-8. PubMed ID: 25921687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]